8406 — China Oral Industry group Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual cashflow statement for China Oral Industry group, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	2.83	-35.8	-18.4	-16.4	-43.5
Depreciation
Amortisation
Non-Cash Items	6.09	17	11.9	7.67	25.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-34.8	40.1	33	1.51	-34.9
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-19.1	28.2	31.3	-5.72	-49
Capital Expenditures	-1.79	-13	-1.84	-0.056	-3.89
Purchase of Fixed Assets
Other Investing Cash Flow Items	0.95	-43.8	2.92	8.84	8.84
Acquisition of Business
Sale of Fixed Assets
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-0.842	-56.9	1.08	8.79	4.95
Financing Cash Flow Items	-1.95	-2.6	-1.01	-0.254	-0.146
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-5.45	31.6	-6	0.868	24.1
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-26.5	3.79	26.9	3.77	-19.9